LESIA CHRISTEN: Open Payments
NPI 1558748806 · NANUET, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,313 in 12 payments from 11 companies in 2025. Trend: 2023 $2,005 · 2024 $1,696 · 2025 $1,313
Food & beverage: $1,176Education: $137
| Company | Payments | Amount |
|---|---|---|
| Medical Device Business Services, Inc. | 2 | $287 |
| Agios Pharmaceuticals, Inc. | 1 | $130 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $125 |
| ABBVIE INC. | 1 | $125 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $124 |
| Lilly USA, LLC | 1 | $120 |
| Novo Nordisk Inc | 1 | $118 |
| Eisai Inc. | 1 | $103 |
| Novartis Pharmaceuticals Corporation | 1 | $82 |
| AstraZeneca Pharmaceuticals LP | 1 | $65 |
Products named: DERMABOND, PYRUKYND, VRAYLAR, ENTYVIO, ZEPBOUND, Wegovy, Leqembi, LEQVIO.
Industry payments across NY — which companies pay providers there.
